Poland – Pharmaceutical products

Original title (Polish): Poland – Pharmaceutical products – Dostawa leków stosowanych w programach lekowych onkologicznych

Samodzielny Publiczny Szpital Wojewódzki Im. Papieża Jana Pawła II W Zamościu · Poland government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

September 30, 2026
Response Due
Active
Status

Opportunity Overview

Abemaciclibum - 3 pozycje asortymentowe | Apalutamidum - 1 pozycja asortymentowa | Atezolizumab - 1 pozycja asortymentowa | Avelumab - 1 pozycja asortymentowa | Bevacizumab - 1 pozycja asortymentowa | Cabozantinibum - 2 pozycje asortymentowe | Dabrafenibum - 2 pozycje asortymentowe | Darolutamidum - 1 pozycja asortymentowa | Durvalumabum - 1 pozycja asortymentowa | Enzalutamidum - 1 pozycja asortymentowa | Ipilimumabum - 2 pozycje asortymentowe | Niraparib - 1 pozycja asortymentowa | Nivolumab - 1 pozycja asortymentowa | Olaparib - 2 pozycje asortymentowe | Osimertinib - 2 pozycje asortymentowe | Palbociclib - 3 pozycje asortymentowe | Pembrolizumab - 1 pozycja asortymentowa | Pertuzumab - 1 pozycja asortymentowa | Ramucirumab - 1 pozycja asortymentowa | Ribociclibum - 1 pozycja asortymentowa | Talazoparib - 1 pozycja asortymentowa | Trametinibum - 2 pozycje asortymentowe | Trastuzumab deruxtecan - 1 pozycja asortymentowa | Trastuzumab emtansine - 1 pozycja asortymentowa | Trifluridine, Tipiracil hydrochloride - 2 pozycje asortymentowe

This Poland Pharmaceuticals opportunity is one most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencySamodzielny Publiczny Szpital Wojewódzki Im. Papieża Jana Pawła II W Zamościu
CountryPoland
CategoryPharmaceuticals
PublishedAugust 31, 2026
Procurement stageRequest for Proposal (RFP)
Response dueSeptember 30, 2026
StatusOpen — accepting responses
Original languagePolish — members read it in their own language
Official sourceView original notice
Last verifiedSeptember 20, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Related Opportunities in Poland

Poland – Pharmaceutical products
Poland – Pharmaceutical products
Poland – Pharmaceutical products
Poland – Pharmaceutical products
Poland – Pharmaceutical products
Poland – Pharmaceutical products
Poland – Pharmaceutical products
Poland – Pharmaceutical products

See every Poland Pharmaceuticals opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free Poland Pharmaceuticals intelligence report in your inbox

A personalized report on Poland Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.